Kelly Paul Edward

Relmada Therapeutics, Inc. · Director

Kelly Paul Edward is listed in public filings as director. This Kelly Paul Edward insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Relmada Therapeutics, Inc. (RLMD). Investors use Kelly Paul Edward's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Relmada Therapeutics, Inc.RLMD$198k90k sharesBuyNov 5, 2025$2.20--